Trump’s FDA Cuts Are Putting Drug Development at Risk
by Caroline Haskins from on (#6VNJ0)
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk's cost-cutting measures could slow drug research and delay FDA approvals.New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk's cost-cutting measures could slow drug research and delay FDA approvals.